Nasdaq · CIK 0001907108
LXEO Lexeo Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 14 d ago. Close $3.23 on Oct 9, 2026, +3% from the 52-week low and -70% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company
Price and insider trades, last year
LXEOOct 9, 2026 · close 3.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Lexeo Therapeutics, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Eric Adler Chief Medical Officer sell | $5,701 615 shares | -1% | +413% from low-9% from high | |
| 30Weak | Jenny Robertson Chief Legal Officer sell | $5,089 549 shares | -1% | +413% from low-9% from high | |
| 40Moderate | Richard Nolan Townsend Chief Executive Officer sell | $10k 1,127 shares | -0% | +413% from low-9% from high | |
| 30Weak | Tai Sandi See Chief Development Officer sell | $3,578 386 shares | -1% | +413% from low-9% from high | |
| 30Weak | Jose Manuel Otero Chief Technical Officer sell | $6,684 721 shares | -1% | +175% from low-56% from high | |
| 35Weak | Eric Adler Chief Medical Officer sell | $30k 3,382 shares | -4% | +435% from low-14% from high | |
| 35Weak | Jenny Robertson Chief Legal Officer sell | $32k 3,526 shares | -5% | +435% from low-14% from high | |
| 50Moderate | Richard Nolan Townsend Chief Executive Officer sell | $117k 13,133 shares | -5% | +435% from low-14% from high | |
| 36Weak | Tai Sandi See Chief Development Officer sell | $35k 3,888 shares | -6% | +435% from low-14% from high | |
| 30Weak | Jose Manuel Otero Chief Technical Officer sell | $19k 2,115 shares | -3% | +435% from low-14% from high | |
| 40Moderate | Richard Nolan Townsend Chief Executive Officer sell | $5,205 1,115 shares | -1% | +175% from low-56% from high | |
| 30Weak | Eric Adler Chief Medical Officer sell | $2,838 608 shares | -1% | +175% from low-56% from high | |
| 30Weak | Tai Sandi See Chief Development Officer sell | $1,783 382 shares | -1% | +175% from low-56% from high | |
| 40Moderate | Richard Nolan Townsend Chief Executive Officer sell | $13k 2,735 shares | -1% | +175% from low-56% from high | |
| 30Weak | Jenny Robertson Chief Legal Officer sell | $2,530 542 shares | -1% | +175% from low-56% from high | |
| 30Weak | Jose Manuel Otero Chief Technical Officer sell | $13k 2,848 shares | -5% | +175% from low-56% from high | |
| 30Weak | Eric Adler Chief Medical Officer sell | $1,623 585 shares | -1% | +81% from low-71% from high | |
| 30Weak | Tai Sandi See Chief Development Officer sell | $1,018 367 shares | -1% | +81% from low-71% from high | |
| 30Weak | Jenny Robertson Chief Legal Officer sell | $1,445 521 shares | -1% | +81% from low-71% from high | |
| 40Moderate | Richard Nolan Townsend Chief Executive Officer sell | $2,979 1,074 shares | -0% | +81% from low-71% from high | |
| 15Weak | Eric Adler Chief Medical Officer sell | $10k 2,359 shares | -3% | - | |
| 0Weak | Richard Nolan Townsend Chief Executive Officer sell | $20k 2,500 shares | -2% | - | |
| 35Weak | Paula H Cholmondeley director buy | $105k 15,000 shares | +96% | - | |
| 0Weak | Richard Nolan Townsend Chief Executive Officer sell | $20k 2,500 shares | -2% | - | |
| 0Weak | Richard Nolan Townsend Chief Executive Officer sell | $40k 5,000 shares | -4% | - |
Transactions
The last 67 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Louis Edward Tamayo Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +54,750 | $0.00 | $0 | 54,750 | 14 d ago |
| Sep 14, 2026 | Narinder Pal Bhalla Chief Medical Officer | AGrant or award Common Stock | +2,714 | $3.58 | $9,713 | 84,908 | 14 d ago |
| Sep 14, 2026 | Richard Nolan Townsend Chief Executive Officer | AGrant or award Common Stock | +2,306 | $2.64 | $6,097 | 376,778 | 14 d ago |
| Sep 14, 2026 | Jose Manuel Otero Chief Operating Officer | AGrant or award Common Stock | +2,110 | $2.64 | $5,579 | 138,288 | 14 d ago |
| Sep 24, 2026 | Richard Nolan Townsend Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +145,500 | $0.00 | $0 | 145,500 | 14 d ago |
| Sep 24, 2026 | Jose Manuel Otero Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +54,750 | $0.00 | $0 | 54,750 | 14 d ago |
| Sep 24, 2026 | Narinder Pal Bhalla Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +54,750 | $0.00 | $0 | 54,750 | 14 d ago |
| Feb 13, 2026 | Narinder Pal Bhalla Chief Medical Officer | AGrant or award Common Stock | +49,500 | $0.00 | $0 | 49,500 | Feb 17, 2026 |
| Feb 13, 2026 | Narinder Pal Bhalla Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +297,000 | $0.00 | $0 | 297,000 | Feb 17, 2026 |
| Nov 18, 2025 | Jenny Robertson Chief Legal Officer | SOpen-market sale Common Stock | -549 | $9.27 | $5,089 | 68,381 | Nov 20, 2025 |
| Aug 18, 2025 | Jose Manuel Otero Chief Technical Officer | SOpen-market sale Common Stock | -721 | $9.27 | $6,684 | 63,476 | Nov 20, 2025 |
| Nov 18, 2025 | Tai Sandi See Chief Development Officer | SOpen-market sale Common Stock | -386 | $9.27 | $3,578 | 65,476 | Nov 20, 2025 |
| Nov 18, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -1,127 | $9.27 | $10k | 240,991 | Nov 20, 2025 |
| Nov 18, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -615 | $9.27 | $5,701 | 72,646 | Nov 20, 2025 |
| Oct 15, 2025 | Jose Manuel Otero Chief Technical Officer | AGrant or award Common Stock | +5,940 | $0.00 | $0 | 66,312 | Oct 17, 2025 |
| Oct 15, 2025 | Tai Sandi See Chief Development Officer | AGrant or award Common Stock | +10,890 | $0.00 | $0 | 69,750 | Oct 17, 2025 |
| Oct 15, 2025 | Richard Nolan Townsend Chief Executive Officer | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 255,251 | Oct 17, 2025 |
| Oct 15, 2025 | Jenny Robertson Chief Legal Officer | AGrant or award Common Stock | +9,900 | $0.00 | $0 | 72,456 | Oct 17, 2025 |
| Oct 15, 2025 | Eric Adler Chief Medical Officer | AGrant or award Common Stock | +9,570 | $0.00 | $0 | 76,643 | Oct 17, 2025 |
| Oct 17, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -12,985 | $8.94 | $116k | 242,266 | Oct 17, 2025 |
| Oct 17, 2025 | Jose Manuel Otero Chief Technical Officer | SOpen-market sale Common Stock | -2,091 | $8.94 | $19k | 64,221 | Oct 17, 2025 |
| Oct 17, 2025 | Tai Sandi See Chief Development Officer | SOpen-market sale Common Stock | -3,844 | $8.94 | $34k | 65,906 | Oct 17, 2025 |
| Oct 17, 2025 | Jenny Robertson Chief Legal Officer | SOpen-market sale Common Stock | -3,486 | $8.94 | $31k | 68,970 | Oct 17, 2025 |
| Oct 17, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -3,344 | $8.94 | $30k | 73,299 | Oct 17, 2025 |
| Oct 17, 2025 | Tai Sandi See Chief Development Officer | SOpen-market sale Common Stock | -44 | $9.56 | $421 | 65,862 | Oct 17, 2025 |
| Oct 17, 2025 | Jose Manuel Otero Chief Technical Officer | SOpen-market sale Common Stock | -24 | $9.56 | $229 | 64,197 | Oct 17, 2025 |
| Oct 17, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -148 | $9.56 | $1,415 | 242,118 | Oct 17, 2025 |
| Oct 17, 2025 | Jenny Robertson Chief Legal Officer | SOpen-market sale Common Stock | -40 | $9.56 | $382 | 68,930 | Oct 17, 2025 |
| Oct 17, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -38 | $9.56 | $363 | 73,261 | Oct 17, 2025 |
| Sep 12, 2025 | Richard Nolan Townsend Chief Executive Officer | AGrant or award Common Stock | +2,193 | $2.64 | $5,798 | 222,251 | Sep 16, 2025 |
| Aug 18, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -1,115 | $4.67 | $5,205 | 220,058 | Sep 10, 2025 |
| Aug 29, 2025 | Louis Edward Tamayo Chief Financial Officer | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 45,000 | Sep 3, 2025 |
| Aug 29, 2025 | Louis Edward Tamayo Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +280,000 | $0.00 | $0 | 280,000 | Sep 3, 2025 |
| Aug 18, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -2,735 | $4.67 | $13k | 220,058 | Aug 20, 2025 |
| Aug 18, 2025 | Jose Manuel Otero Chief Technical Officer | SOpen-market sale Common Stock | -2,848 | $4.67 | $13k | 60,372 | Aug 20, 2025 |
| Aug 18, 2025 | Tai Sandi See Chief Development Officer | SOpen-market sale Common Stock | -382 | $4.67 | $1,783 | 58,860 | Aug 20, 2025 |
| Aug 18, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -608 | $4.67 | $2,838 | 67,073 | Aug 20, 2025 |
| Aug 18, 2025 | Jenny Robertson Chief Legal Officer | SOpen-market sale Common Stock | -542 | $4.67 | $2,530 | 62,556 | Aug 20, 2025 |
| Jun 26, 2025 | Mette Kirstine Agger director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 26, 2025 | Steven Altschuler director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 26, 2025 | Paula H Cholmondeley director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 26, 2025 | Brenda Cooperstone director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 26, 2025 | Reinaldo M Diaz director | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2025 |
| Jun 26, 2025 | Timothy Van Hauwermeiren director | AGrant or award Stock Option (right to buy)derivative | +22,916 | $0.00 | $0 | 22,916 | Jun 30, 2025 |
| Jun 26, 2025 | Tolga Tanguler director | AGrant or award Stock Option (right to buy)derivative | +14,583 | $0.00 | $0 | 14,583 | Jun 30, 2025 |
| May 16, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -585 | $2.77 | $1,623 | 67,681 | May 20, 2025 |
| May 16, 2025 | Tai Sandi See Chief Development Officer | SOpen-market sale Common Stock | -367 | $2.77 | $1,018 | 59,242 | May 20, 2025 |
| May 16, 2025 | Jenny Robertson Chief Legal Officer | SOpen-market sale Common Stock | -521 | $2.77 | $1,445 | 63,098 | May 20, 2025 |
| May 16, 2025 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock | -1,074 | $2.77 | $2,979 | 221,173 | May 20, 2025 |
| Mar 14, 2025 | Jenny Robertson Chief Legal Officer | AGrant or award Common Stock | +5,720 | $2.61 | $15k | 63,619 | Apr 9, 2025 |
| Mar 14, 2025 | Jose Manuel Otero Chief Technical Officer | AGrant or award Common Stock | +5,720 | $2.61 | $15k | 63,220 | Apr 9, 2025 |
| Mar 14, 2025 | Tai Sandi See Chief Development Officer | AGrant or award Common Stock | +5,720 | $2.61 | $15k | 59,609 | Apr 9, 2025 |
| Mar 14, 2025 | Richard Nolan Townsend Chief Executive Officer | AGrant or award Common Stock | +2,128 | $2.61 | $5,554 | 222,247 | Apr 1, 2025 |
| Feb 19, 2025 | Eric Adler Chief Medical Officer | SOpen-market sale Common Stock | -2,359 | $4.41 | $10k | 68,266 | Feb 21, 2025 |
| Jan 7, 2025 | Eric Adler Chief Medical Officer | AGrant or award Common Stock | +43,750 | $0.00 | $0 | 70,625 | Jan 10, 2025 |
| Jan 7, 2025 | Eric Adler Chief Medical Officer | AGrant or award Stock Option (right to buy)derivative | +87,500 | $0.00 | $0 | 87,500 | Jan 10, 2025 |
| Dec 10, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Common Stock10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | Dec 12, 2024 |
| Dec 10, 2024 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,500 | $8.20 | $20k | 120,695 | Dec 12, 2024 |
| Dec 10, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 118,655 | Dec 12, 2024 |
| Nov 25, 2024 | Paula H Cholmondeley director | POpen-market purchase Common Stock | +15,000 | $6.99 | $105k | 30,627 | Nov 26, 2024 |
| Nov 11, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Common Stock10b5-1 | +2,500 | $2.33 | $5,825 | 123,195 | Nov 13, 2024 |
| Nov 11, 2024 | Tolga Tanguler director | AGrant or award Stock Option (right to buy)derivative | +36,000 | $0.00 | $0 | 36,000 | Nov 13, 2024 |
| Nov 11, 2024 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -2,500 | $7.82 | $20k | 120,695 | Nov 13, 2024 |
| Nov 11, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 121,155 | Nov 13, 2024 |
| Oct 10, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Common Stock10b5-1 | +5,000 | $2.33 | $12k | 125,695 | Oct 15, 2024 |
| Oct 10, 2024 | Richard Nolan Townsend Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -5,000 | $8.10 | $40k | 120,695 | Oct 15, 2024 |
| Oct 10, 2024 | Richard Nolan Townsend Chief Executive Officer | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 123,655 | Oct 15, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Eric AdlerChief Medical Officer
- Mette Kirstine Aggerdirector
- Steven Altschulerdirector
- Narinder Pal BhallaChief Medical Officer
- Paula H Cholmondeleydirector
- Brenda Cooperstonedirector
- Reinaldo M Diazdirector
- Jose Manuel OteroChief Technical Officer
- Jenny RobertsonChief Legal Officer
- Tai Sandi SeeChief Development Officer
- Louis Edward TamayoChief Financial Officer
- Tolga Tangulerofficer, director
- Richard Nolan TownsendChief Executive Officer
- Timothy Van Hauwermeirendirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.